Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Bio Cătina Coop Promotes European Organic Products at Bio Marché in Switzerland
EIN Presswire
Three days of promotion, tasting and information dedicated to European Organic Sea buckthorn and recognition of the European Union Organic logo.
HUTCHMED Highlights SAFFRON Global Phase III Data Presented at ESMO Congress 2026 and Simultaneously Published in The New England Journal of Medicine
GlobeNewswire, Inc.
— ORPATHYS® plus TAGRISSO® reduced the risk of disease progression or death by 45% and the risk of death by 32% in MET-driven EGFR-mutated lung cancer after progression on TAGRISSO® — — ORPATHYS® plus TAGRISSO® extended median OS by nearly 5...
2-stage Screw Compressor Factory: AIRERA Secures TUV Class 0 Certification to Lead Pharma and Food-Grade Air
EIN Presswire
SHANGHAI, SHANGHAI, CHINA, October 25, 2026 /EINPresswire.com/ -- Pharma and Food-Grade Air Solutions In highly sensitive industrial manufacturing, particularly within the pharmaceutical and food and beverage sectors, the procurement logic for...
More than 160 states developed practical steps to uphold humanity in war
International Committee of the Red Cross
"We witness emboldened warring parties adopting overly permissive or outright dismissive interpretations of international humanitarian law that perpetuate rather than prevent suffering," said Mirjana Spoljaric, president of the International...
Relay Market Size to Reach $15.65 billion at 5.0% CAGR through 2031 | MarketsandMarkets™
GlobeNewswire, Inc.
Delray Beach, FL, Nov. 03, 2026 (GLOBE NEWSWIRE) -- MarketsandMarkets™ projects, the global Relay Market size is projected to reach USD 15.65 billion by 2030 from USD 11.75 billion in 2026, at a CAGR of 5.0% during the forecasted period.
Release Therapeutics’ CNS-Targeted Technology Earns 2026 Disruptive Innovation Award from Geneva University Hospitals
EIN Presswire
The Rocket Innovation Award recognises advances in sustained therapeutic protein delivery to the CNS, including Myo-P5® for Sanfilippo syndrome type IIIA GENEVA, SWITZERLAND, October 23, 2026 /EINPresswire.com/ -- Campus Innovation Park –...
Santhera’s Licensing Partner, Nxera Pharma, Submits Marketing Authorization Application for AGAMREE® (Vamorolone) in South Korea
GlobeNewswire, Inc.
Pratteln, Switzerland, October 23, 2026 – Santhera Pharmaceuticals (SIX: SANN) today notes that its licensing partner Nxera Pharma Co., Ltd. (“Nxera”) has submitted a Marketing Authorization Application (MAA) to South Korea’s Ministry of Food and...
Krystal Biotech Announces Third Quarter 2026 Financial and Operating Results
GlobeNewswire, Inc.
$127.3 million in 3Q VYJUVEK global revenue and $1.1 billion since launch VYJUVEK pricing negotiations in Germany and Italy completed KB113 clinical data demonstrate regression in more than 80% of assessed basal cell carcinoma lesions in patients...
Poland's Ministry of Health Signs Agreement with HealthAI, Advancing Responsible AI Governance in Health Across Europe
EIN Presswire
Poland signs MoU with HealthAI, charting course for Poland's full membership in the GRN and reinforcing Europe's growing commitment to responsible AI in health.
Nxera Pharma Submits Marketing Authorization Application for Vamorolone in South Korea for the Treatment of Duchenne Muscular Dystrophy
GlobeNewswire, Inc.
Submission marks an important milestone towards bringing a new treatment option to patients with DMD in South Korea.
Dr. Falk Pharma and Renexxion Reach Alignment with FDA and EMA on Phase 3 Program for Naronapride in Gastroparesis
GlobeNewswire, Inc.
FREIBURG, Germany and ROSCREA, Ireland, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Dr. Falk Pharma GmbH (“Dr. Falk Pharma”), a research-based pharmaceutical company specializing in digestive and metabolic medicine, and Renexxion Ireland Limited...
ONWARD Medical Announces the Appointment of Fouad Azzam to its Board of Directors
GlobeNewswire, Inc.
EINDHOVEN, the Netherlands, Oct. 21, 2026 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US OTCQX: ONWRY), the neurotechnology company pioneering spinal cord stimulation therapies to restore movement, function, and independence in...
Hybrida Farms Runs Medical Cannabis Production on Costa Rica’s 98.6% Renewable Grid
EIN Presswire
The licensed Central American operation runs on a national grid. 98.6% renewable in 2025 and holds Costa Rica’s first cannabis medicine manufacturing license CARTAGO, COSTA RICA, October 20, 2026 /EINPresswire.com/ -- Hybrida Farms, the company...
Rapid Micro Biosystems to Participate at the PDA Pharmaceutical Microbiology Conference 2026
GlobeNewswire, Inc.
LEXINGTON, Mass., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient...
ROVENSA NEXT launches “We Have it Under Biocontrol” to Help Growers Anticipate Changing Pest and Disease Pressure
EIN Presswire
We Have It Under Biocontrol, expands Biosolutionize Agriculture’s “Real Challenges.
CRISPR Therapeutics Announces the Appointment of Siva Sakhamuri, Ph.D., as Chief Technical Officer
GlobeNewswire, Inc.
ZUG, Switzerland and BOSTON, Nov. 02, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), today announced the appointment of Sivakesava (Siva) Sakhamuri, Ph.D., as Chief Technical Officer, effective immediately.
Matternet Expands NHS Drone Delivery Network to Great Ormond Street Hospital
GlobeNewswire, Inc.
MOUNTAIN VIEW, Calif., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Matternet, Inc. (OTCQB: MTTN) (“Matternet” or the “Company”), a leading developer of autonomous drone networks for ultra-fast, low-cost and zero-emissions delivery, today announced the...
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2026 Financial Results
GlobeNewswire, Inc.
– CASGEVY® revenue of $99 million in the third quarter of 2026, up 30% quarter-over-quarter and nearly six times the third quarter of 2025 – – CASGEVY approved in the U.K. for children 5 years of age and older with severe SCD or TDT, and in the...
Oculis Completes Randomization in PREDICT-1 Registrational Trial of Licaminlimab for TNFR1-Mediated Dry Eye Disease
GlobeNewswire, Inc.
High-Responder Target Enrichment: 2/3 of the 176 enrolled patients carry the target TNFR1 genetic variant previously linked to enhanced clinical response in Phase 2 trials Precision Medicine Approach in a Large Market: Licaminlimab is positioned...
Lexeo Therapeutics to Host Educational Event Focused on Clinical Endpoints and Outcome Measures in PKP2-ACM
GlobeNewswire, Inc.
NEW YORK, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (Nasdaq: LXEO) a clinical stage company focused on reshaping the path of genetic diseases with high unmet need, today announced that it will host an educational investor event,...
Sign up for:
Switzerland Health Monitor
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.